Gilead Sciences· @GileadSciences · X·· 2026-07-21AI 评分42
AI 导读
#GileadNews：在 #AIDS2026 上，我们与 @Merck 合作，展示我们III期试验的新数据，评估一种用于病毒学抑制的成人HIV感染者的在研长效口服治疗。 在此阅读完整新闻稿：https://gilead.inc/3TfiSiP
正文
#GileadNews: At #AIDS2026, in collaboration with @Merck, we’re presenting new data from our Phase 3 trials evaluating an investigational long-acting oral treatment for adults with virologically suppressed HIV.
Read the full press release here: https://gilead.inc/3TfiSiP
来源：Gilead Sciences · x.com